Here, we report the establishment of the human iPS cell line N1-FiPS4F#7 generated from skin cells of a patient with no rheumatic diseases, thus obtaining an appropriate control iPS cell line for researchers working in the field of rheumatic diseases. The reprogramming factors Oct4, Sox2, Klf4 and c-Myc were introduced using a non-integrating reprogramming strategy involving Sendai Virus.
Keywords: Cell line; Embryoid body; Human iPS; Pluripotency; Reprogramming; Sendai virus.
Copyright © 2019 The Authors. Published by Elsevier B.V. All rights reserved.